Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
Recruiting · NCT06611813 · Registry updated 2025-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2025-08-12 | NCT06611813 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| First Affiliated Hospital of Zhejiang University | 201 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Harbin Medical University Cancer Hospital | Harbin | China | 35 |
| Jinhua municipal central hospital | Jinhua | China | 10 |
| Nanchang People's Hospital | Nanchang | China | 1 |
| Shaanxi Provincial Cancer Hospital | Xi'an | China | 2 |
| The First Affiliated Hospital of Anhui Medical University | Hefei | China | 28 |
| The First Affiliated Hospital of Zhejiang University | Hangzhou | China | 4 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 61 |
| The Second Affiliated Hospital of Xi'an Jiaotong University | Xi'an | China | 1 |
| Xinjiang Medical University Affiliated Cancer Hospital | Ürümqi | China | 3 |
| Zhejiang Cancer Hospital | Hangzhou | China | 40 |
| Zhongshan Hospital, Fudan University | Shanghai | China | 37 |